Instead, it is about reducing the appearance of dark spots and creating a healthy, luminous look
By acting on both systems at once, tirzepatide can deliver stronger effects on appetite, fullness, and metabolic health than GLP-1 medications alone
This is why tracking appetite and eating behaviors, rather than just weight, gives you a more accurate picture of whether semaglutide is working during the early weeks
Triple-Hormone-Receptor Agonist Retatrutide for Obesity Phase 2, NEJM , 2023 ClinicalTrials.gov TRIUMPH-1 (NCT05929066), TRIUMPH-2 (NCT05929079), TRIUMPH-3 (NCT05882045), TRIUMPH-4 (NCT05931367) FDA Wegovy prescribing information, 2025 FDA Zepbound (tirzepatide) prescribing information, 2024 Medical disclaimer: This article is for informational purposes only